2020
The on-site operations at the CS lab temporarily closed in March due to the COVID-19 pandemic, and resumed partially in the summer. We are grateful to be back!
We received an R13 grant from NIAAA in collaboration with the Colloca lab for organizing an interdisciplinary international conference on placebo studies, in 2021.
Our first post-doc Dr. Angela Verma, PhD joined the lab in May amidst the height of pandemic – welcome Angela!!
John Sivinski officially joined our lab – Welcome, John!! we are so glad you decided to stay with our group.
2019
Last participant enrolled in the 5-year NIAAA-funded Alcohol Biomarkers study. Data analysis begins.
John Sivinski started an internship with us – He is a student at the BioTechnical Institute of Maryland.
2018
The CS lab receives a 5-year R01 grant from NIAAA ($2,857,615) to study genomic predictors of placebo response in alcohol treatment trials!!!
Jessica Cornell, BS joined the lab – welcome to our team Jessica! Jessica is a 2017 graduate of James Madison University, Virginia.
We are thrilled to collaborate with Dr. Eric Weintraub, MD (Director, Division of Addiction Research and Treatment, UMSOM) on a 3-year HRSA funded project for improving access to treatment of opioid use disorder in rural areas in Maryland. HRSA Award Number: 1 G01RH32161-01-00
2017
Andrew Conchas, BS joined the lab – welcome to our team Andrew! Andrew is a 2016 graduate of the University of Maryland College Park (UMCP).
A big thank you to High school students Alicia Whye (Park School, Brooklandville, MD; class of 2018) and Cianna Bisant (Atholton High School, Columbia, MD; class of 2018) and UMCP undergraduate student Joshua Blanchard for volunteering in our lab. We are certain that you will all do great things in sciences and medicine!
2016
We started genetic testing for a promising new phase 2 pharmacogenetic trial funded by a 5-year RO1 award from NIAAA to Drs. Bankole A. Johnson and Melanie Bennett (Dr. Seneviratne, Co-I).
2015
The Alcohol Biomarkers study (Biomarkers to Measure Treatment Response for Alcoholism) resumes at UMB! First participant enrolled! Thank you to faculty and staff at University of Virginia for their support in initiating the project.
2014
OUR JOURNEY BEGINS – We established our lab at the UMSOM Institute for Genome Sciences (IGS)!!!
The CS lab started genetic testing for our first collaborative pharmacogenetic project that tested efficacy of ondansetron for the treatment of alcohol use disorder (AUD) in selective genetic subgroups. The study is funded by a 5-year RO1 award from the NIAAA to Drs. David Gorelick and Henry Kranzler (Dr. Seneviratne, Co-I).
p